TOL-N -2.47 NOG-N -0.15 CPA-N 0.46 PBH-T 0.25 BEP.UN-T 0.62 NFI-T 0.11 SII-T 1.61
Nurosene Health (MEND-CSE)

Nurosene Health (MEND-CSE)

0.00
-0.00 (0.00%)
23 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0

Related posts

Nervous markets await Nvidia
BUY

Nurosene Health(MEND-CSE)

Jan 19, 2023
AI technology that lets drug companies screen out participants for trials. Pinpoints who they should include and who they shouldn't, leading to more success of trials. Doing an excellent job. Waiting for a bigger contract from a bigger company. Hasn't performed that well, but worst is behind them.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
N/A

Stock price when the opinion was issued

Healthcare
Unspecified

Nurosene Health(MEND-CSE)

Nov 21, 2022
It has AI technology which helps drug companies through the trial process. Its technology targets and enrolls new patients with the right type of background and makeup.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
N/A

Stock price when the opinion was issued

Healthcare
PAST TOP PICK

Nurosene Health(MEND-CSE)

Oct 21, 2022

(A Top Pick Nov 19/21, Down 88%) A.I. technology for pharmaceutical industry. Allows for further identification of illness within patients. Technology building to the point of being commercial. Looking to the future for a robust sales pipeline. No profits yet. Will continue to hold shares.

Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
N/A

Stock price when the opinion was issued

Healthcare
BUY

Nurosene Health(MEND-CSE)

Feb 23, 2022
AI software to help drug companies to purpose different compounds to tell what's effective and what's not. Part of the small cap selloff. Continues to reach significant milestones and sign contracts. Revenue and cashflow should improve over next year. A takeout possibility.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
N/A

Stock price when the opinion was issued

Healthcare
BUY

Nurosene Health(MEND-CSE)

Dec 30, 2021
Stock's pulled back due to tax-loss selling. Business itself is interesting with the move to health and wellness. AI acquisition should let them work with big drug companies to study effects on mental health. This year should be strong as they roll out products and gain market share.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
N/A

Stock price when the opinion was issued

Healthcare
TOP PICK

Nurosene Health(MEND-CSE)

Nov 19, 2021
They are in the healthcare technology sector. Specializing in brain health. They have an app and technology tool that develops a baseline for everyone. Then they have actionable items to monitor and improve brain health. They have a direct to consumer subscription service.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
N/A

Stock price when the opinion was issued

Healthcare
WATCH

Nurosene Health(MEND-CSE)

Jun 29, 2021
They just IPO'd that he participated in. It's on the CSE, so he didn't make it a top pick today. Brain health is moving to the forefront. They combine tech and natural ingredients to promote brain health, like apps to keep the mind sharp. Michael Phelps is on the board among other notables. He's watching it. The company has room to grow.
Bruce Campbell (2)Bruce Campbell (2)
Owned
Unlock Rating
N/A

Stock price when the opinion was issued

Healthcare
Showing 1 to 7 of 7 entries
  • «
  • ‹
  • 1
  • ›
  • »

Nurosene Health(MEND-CSE) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Nurosene Health is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Nurosene Health(MEND-CSE) Frequently Asked Questions

What is Nurosene Health stock symbol?

Nurosene Health is a OTC stock, trading under the symbol MEND-CSE on the (). It is usually referred to as or MEND-CSE

Is Nurosene Health a buy or a sell?

In the last year, there was no coverage of Nurosene Health published on Stockchase.

Is Nurosene Health a good investment or a top pick?

Nurosene Health was recommended as a Top Pick by on . Read the latest stock experts ratings for Nurosene Health.

Why is Nurosene Health stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Nurosene Health worth watching?

0 stock analysts on Stockchase covered Nurosene Health In the last year. It is a trending stock that is worth watching.

What is Nurosene Health stock price?

On , Nurosene Health (MEND-CSE) stock closed at a price of $.

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

BLX-N 0.47$40.83
URB-T 0.07$6.57
NPI-T 0.49$22.43
BCE-T -0.23$30.81
PPL-T -0.28$50.51

Today's Top Picks

TOL-N -2.47$117.79
NOG-N -0.15$29.8
CPA-N 0.46$111.64
PBH-T 0.25$82.29
BEP.UN… 0.62$35.92

Popular Articles

Latest Sell Signals

CPX-T -0.4$54.64
RCI.B-… 0.59$43.88
BMO-T 1.74$154.09
MG-T -0.73$56
BNS-T -0.02$74.96

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Rebecca Teltscher

Rebecca Teltscher

Newhaven Asset Management

Rick Rule

Rick Rule

Rule Investment Media

Stockchase Insights

Stockchase Insights

5i Research

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica